Search

everythinglearnresearchcommunity

for

Search:↓

Chromosomal differences affect how muscle cells respond to testosterone.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

A new method effectively predicts estrogen-related health effects for early screening.

5α-reductases increase epitestosterone's effect on androgen receptors.

Prepubertal girls have higher sex steroid levels than boys, possibly leading to earlier puberty.

A new method was developed to make finasteride for treating hair loss.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Activating androgen receptors in muscle can increase muscle mass and reduce fat.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Researchers made two new compounds that could be used for medicine.

TCDD reduces EGF receptors in the liver, affecting growth and development.

PCPA induces hypersexual behavior in male rats regardless of age or castration status.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Taking 100 mg of DHEA daily for 16 weeks did not change metabolic and reproductive health significantly but increased certain ovarian markers with minimal side effects.

DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

New compounds were made that are promising for prostate cancer therapy.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The compounds tested could potentially treat hair loss and alopecia.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

MPA increases cancer spread by boosting Eph A2 activity.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.